These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30710502)

  • 1. CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
    Sheng Z; Xu Y; Li F; Wang S; Huang T; Lu P
    Exp Cell Res; 2019 Mar; 376(1):11-17. PubMed ID: 30710502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway.
    Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W
    Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
    Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
    Asare Y; Ommer M; Azombo FA; Alampour-Rajabi S; Sternkopf M; Sanati M; Gijbels MJ; Schmitz C; Sinitski D; Tilstam PV; Lue H; Gessner A; Lange D; Schmid JA; Weber C; Dichgans M; Jankowski J; Pardi R; de Winther MP; Noels H; Bernhagen J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2766-E2775. PubMed ID: 28292897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
    Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
    Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
    Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
    Mao L; Le S; Jin X; Liu G; Chen J; Hu J
    Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol ameliorates angiotensin II-induced cardiac hypertrophy by promoting dissociation of the Nur77-LKB1 complex and activating the AMPK pathway.
    Lin X; Zhang H; Chu Y; Zhang Y; Xu C; Xie H; Ruan Q; Lin J; Huang CK; Chai D
    J Cell Mol Med; 2024 Jan; 28(1):e18028. PubMed ID: 37985436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
    Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
    Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice.
    Omede A; Zi M; Prehar S; Maqsood A; Stafford N; Mamas M; Cartwright E; Oceandy D
    Biochem Biophys Res Commun; 2016 Oct; 479(4):708-714. PubMed ID: 27693579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
    Zhu J; Ning RB; Lin XY; Chai DJ; Xu CS; Xie H; Zeng JZ; Lin JX
    Am J Hypertens; 2014 Aug; 27(8):1112-24. PubMed ID: 24603314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
    Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
    Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Role of ADAMTS2 (A Disintegrin and Metalloproteinase With Thrombospondin Motifs 2) in Cardiac Hypertrophy Induced by Pressure Overload.
    Wang X; Chen W; Zhang J; Khan A; Li L; Huang F; Qiu Z; Wang L; Chen X
    Hypertension; 2017 Jun; 69(6):1060-1069. PubMed ID: 28373586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
    Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
    Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.